Skip to search formSkip to main contentSkip to account menu

SDZ 202-250

Known as: SDZ202250, SDZ 202 250, SDZ202 250 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Morphine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine.
1995
1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humans.
Scopolamine-induced cognitive impairment was used in healthy men to evaluate the central nervous system activity of the new… 
1994
1994
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent
SummaryThe effects of the new inotropic agent, SDZ 218-135 [(+)-(S)-4-[3-(4-diphenyl-methyl-1-piperazinyl)-2-hydroxy-propyl]-6-(2… 
1991
1991
[SDZ HDC 912 as a dopamine receptor partial agonist: the effect on spontaneous locomotor activity in mice].
To clarify if N-((8-alpha)-2-chloro-6-methylergoline-8-yl)-2,2- dimethylpropanamide (SDZ HDC 912) acts as a dopamine receptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)